March 23, 2023 at 8:53 am

Potential TikTok ban sends advertisers scrambling

TikTok app logo is seen in this illustration taken, August 22, 2022. REUTERS/Dado Ruvic/Illustration/File Photo March 23 (Reuters) – Advertisers are seeking any assurances from TikTok, the viral app that helped usher in a wave of short-form video across social media, as the Chinese-owned company again faces a potential ban in the U.S. over national… [Read More]
March 22, 2023 at 2:54 pm

Connect Biopharma: Phase 2b Data Shows Rapid and Sustained Improvement in Atopic Dermatitis

Global clinical-stage biopharmaceutical company, Connect Biopharma (Nasdaq: CNTB), has announced that post hocdata analysis from its Phase 2b CBP-201 global trial in moderate-to-severe atopic dermatitis (AD) showed a rapid and sustained improvement in AD signs and symptoms. Connect’s share price climbed 19% following the news this week. Highlights  Researchers reported that CBP-201 demonstrated rapid improvement… [Read More]
March 22, 2023 at 11:10 am

GameStop soars on short squeeze after swinging to profit, meme stocks rally

March 22 (Reuters) – Meme stock GameStop Corp (GME.N) jumped nearly 50% in early trading on Wednesday as the video game retailer’s first profitable quarter in two years squeezed bearish investors and ignited a surge in other stocks popular among retail traders. AMC Entertainment Holdings Inc (AMC.N) gained 5.3%, while Bed Bath & Beyond (BBBY.O)… [Read More]
March 22, 2023 at 10:56 am

SuperCom: Romanian Ministry of Interior Places $7.1M Follow-On Order

SuperCom (Nasdaq: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, has received a follow-on order valued at $7.1 million from Romania’s Ministry of Interior for the country’s National Electronic Monitoring (EM) Project. The EM project includes the deployment of SuperCom’s PureSecurity EM Suite for domestic violence monitoring, GPS Tracking… [Read More]
March 22, 2023 at 10:37 am

Asensus Surgical Receives 510(k) Clearance from FDA

Medical device company, Asensus Surgical, Inc., (NYSE American: ASXC), has received 510(k) clearance from the FDA for an expanded indication to treat pediatric patients with the Senhance® System. Highlights  Asensus’ Senhance System combines 3mm instrumentation, 5mm camera scope, haptic feedback, and advanced clinical intelligence provided by the Intelligent Surgical Unit™ to bring the benefits of… [Read More]
March 22, 2023 at 1:54 am

Janet Yellen Prepared To Protect Smaller U.S. Banks

In a speech to the American Bankers Association, Treasury Secretary Janet L. Yellen expressed confidence in the nation’s banks but also said she was prepared to take additional action to safeguard smaller financial institutions, as the Biden administration and federal regulators worked to contain fallout from fears over the stability of the banking system. She… [Read More]
March 21, 2023 at 3:12 pm

Quoin Fortifies Position to Potentially Deliver First Treatment for Netherton Syndrome

In a significant step for the clinical-stage specialty pharmaceutical company and Netherton Syndrome patients, Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) has initiated dosing of the first patient in its open-label clinical trial. The ongoing trial is evaluating the safety and efficacy of Quoin’s lead candidate, QRX003, in Netherton Syndrome patients who are currently receiving off-label systemic… [Read More]